Enteric Disease Testing Market by Product Type, Distribution Channel, End User 2024-2032

The global enteric disease testing market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024-2032.

More Info:- https://www.imarcgroup.com/enteric-disease-testing-market

1. Global Enteric Disease Testing Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved

2. About IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Highlight and Description According to the latest report by IMARC Group, titled  "Enteric Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,"  the  global enteric disease testing market size reached US$ 4.2 Billion in 2023. Enteric diseases are caused by the ingestion of food or water contaminated by microbial toxins and microorganisms. These microorganisms enter through the mouth by coming in contact with an infected person's feces or with animals and their environments, attacking the gastrointestinal tract. Enteric diseases can cause symptoms like diarrhea, nausea, vomiting, fever, chills, abdominal cramps, and a loss of appetite. In recent years, the approval for the commercialization of novel technologies and the launch of new products have revolutionized enteric disease testing. Request for a PDF sample of this report: https://www.imarcgroup.com/enteric-disease-testing-market/requestsample

4. Report Description Global Enteric Disease Testing Market Trends : The increasing cases of enteric diseases, such as cholera, amebiasis, Campylobacteriosis and Hepatitis A, represent the primary factor that positively impacts the global enteric disease testing market. This can be attributed to the unhygienic conditions, unsafe drinking water and poor sanitation. Besides this, with the recent outbreak of coronavirus disease (COVID-19), testing for enteric diseases has increased as the virus is variably found in human enteric samples during the course of infection. As a result, many healthcare centers are undertaking research to discover the co-relation between enteric disease and COVID-19. Furthermore, as individuals are becoming more aware of the benefits of early diagnosis, they are increasingly opting for the testing of enteric diseases. The leading healthcare companies are investing in research and development (R&D) activities to advance the enteric disease testing technologies to increase the efficiency of diagnosis. Some of the other factors, such as improving healthcare infrastructure, various technological advancements and the emerging trend of medical tourism, are expected to create a positive outlook for the market. Looking forward, the market is expected to grow at a CAGR of 3.1% during 2024-2032. View Report TOC, Figures and Tables : https://www.imarcgroup.com/enteric-disease-testing-market

5. Report Segmentation Breakup by Product Type: Reagents and Consumables Equipment   Breakup by Technique: Molecular Diagnostics Immunodiagnostics Breakup by Disease Type: Bacterial Enteric Disease C. Difficile Campylobacteriosis Cholera E. Coli H. Pylori

6. Report Segmentation Salmonellosis Shigellosis Viral Enteric Disease Rotavirus Norovirus Others Parasitic Enteric Disease Amebiasis Cryptosporidiosis Giardiasis Breakup by End User: Hospital Diagnostic Laboratories

7. Report Segmentation Independent Diagnostic Laboratories Academic and Research Institutes Others Breakup by Region: North America Asia-Pacific Europe Latin America Middle East and Africa

8. Competitive Landscape with Key Players Abbott Laboratories BD (Becton, Dickinson and Company) Bio-Rad Laboratories Inc. Biomerica Inc. Biomérieux SA Cepheid Inc. (Danaher Corporation) Coris BioConcept DiaSorin Meridian Bioscience Inc. Quest Diagnostics.

9. Key Questions Answered in the Report

10. Key Questions Answered in the Report

11. Table of Contents 1    Preface 2    Scope and Methodology     2.1    Objectives of the Study     2.2    Stakeholders     2.3    Data Sources         2.3.1    Primary Sources         2.3.2    Secondary Sources     2.4    Market Estimation         2.4.1    Bottom-Up Approach         2.4.2    Top-Down Approach     2.5    Forecasting Methodology 3    Executive Summary 4    Introduction     4.1    Overview     4.2    Key Industry Trends 5    Global Enteric Disease Testing Market     5.1    Market Overview     5.2    Market Performance     5.3    Impact of COVID-19   5.4    Market Forecast 6     Market Breakup by Product Type 6.1 Reagents and Consumables 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Equipment 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Technique 7.1 Molecular Diagnostics 7.1.1 Market Trends 7.1.2 Market Forecast        

12. Table of Contents 7.2 Immunodiagnostics 7.2.1 Market Trends 7.2.2 Market Forecast 8 Market Breakup by Disease Type 8.1 Bacterial Enteric Disease 8.1.1 Market Trends 8.1.2 Major Types 8.1.2.1 C. Difficile 8.1.2.2 Campylobacteriosis 8.1.2.3 Cholera 8.1.2.4 E. Coli 8.1.2.5 H. Pylori 8.1.2.6 Salmonellosis 8.1.2.7 Shigellosis 8.1.3 Market Forecast 8.2 Viral Enteric Disease 8.2.1 Market Trends 8.2.2 Major Types 8.2.2.1 Rotavirus 8.2.2.2 Norovirus 8.2.2.3 Others 8.2.3 Market Forecast 8.3 Parasitic Enteric Disease 8.3.1 Market Trends 8.3.2 Major Types 8.3.2.1 Amebiasis 8.3.2.2 Cryptosporidiosis 8.3.2.3 Giardiasis 8.3.3 Market Forecast For more information, visit : https://www.imarcgroup.com/enteric-disease-testing-market/toc

13. Partial List of Clients

14. Partial List of Clients

15. Disclaimer © 2024 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

16. Contact Us Visit us at : https://www.imarcgroup.com [phone] [email protected] Stay With Us: